Daiken Biomedical Co., Ltd. (7780.TW) — Stock Score Summary

Daiken Biomedical Co., Ltd. (7780.TW) has a MoatMap StockRank of 8/100 based on Quality (60/100), Value (11/100), and Momentum (18/100) factor scores. The current signal is STRONG SELL. While Daiken Biomedical shows a decent quality score of 60, it operates in the highly fragmented Taiwanese health supplement market and lacks any alignment with our core 18-month macro themes.

Daiken Biomedical Co., Ltd. develops, markets, and distributes high-quality dietary supplements and functional health foods. The company focuses on scientifically backed formulations, including fish oil, probiotics, and lutein, sold through e-commerce and retail pharmacy channels. Its competitive advantage is driven by strong brand equity, rigorous clinical testing of ingredients, and an agile direct-to-consumer marketing strategy.

Key Financial Metrics

Price$0.59
Market Cap$452M
P/E (TTM)363.00
P/E (Forward)18.02
Price/Book2.66
Return on Equity10.0%
Return on Invested Capital7.6%
Debt/Equity2.13
Gross Margin62.3%
Operating Margin13.4%
Revenue Growth38.6%
Dividend Yield1.9%
Free Cash Flow$41K

Daiken Biomedical Co., Ltd. operates in the Packaged Foods industry, part of the Consumer Defensive sector (Taiwan).

Frequently Asked Questions

What is Daiken Biomedical Co., Ltd.’s (7780.TW) StockRank?
MoatMap’s StockRank for Daiken Biomedical Co., Ltd. (7780.TW) is 8/100, with a Strong Sell signal. It is a composite of Quality (60), Value (11), and Momentum (18) factor ranks across MoatMap’s 19,000+ stock universe.
Does Daiken Biomedical Co., Ltd. have an economic moat?
Daiken Biomedical Co., Ltd. (7780.TW) has a Quality factor score of 60/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Daiken Biomedical Co., Ltd. a buy, hold, or sell?
MoatMap’s current signal for Daiken Biomedical Co., Ltd. (7780.TW) is Strong Sell, based on a StockRank of 8/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Daiken Biomedical Co., Ltd. in?
Daiken Biomedical Co., Ltd. (7780.TW) operates in the Consumer Defensive sector, specifically the Packaged Foods industry (Taiwan).
Browse all ranked stocks7780.TW deep dive reportAI ChampionsHow we score stocksSense-check another stock